Fat and Fiber: How the Controlled Attenuation Parameter Complements Noninvasive Assessment of Liver Fibrosis

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - a prospective cohort study with paired transient elastography examinations

(2014) G. L.-H. Wong et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Normal Controlled Attenuation Parameter Values: A Prospective Study of Healthy Subjects Undergoing Health Checkups and Liver Donors in Korea

(2014) Young Eun Chon et al.   DIGESTIVE DISEASES AND SCIENCES

Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B

(2014) Yu-Qiang Mi et al.   DIGESTIVE DISEASES AND SCIENCES

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B

(2013) Grace Lai-Hung Wong et al.   JOURNAL OF HEPATOLOGY

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

(2012) Victor Lédinghen et al.   LIVER INTERNATIONAL

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

(2012) Robert P. Myers et al.   LIVER INTERNATIONAL

Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

(2011) Michael R. Charlton et al.   GASTROENTEROLOGY

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

(2011) Vincent Wai-Sun Wong et al.   GUT

Hepatitis B virus infection and fatty liver in the general population

(2011) Vincent Wai-Sun Wong et al.   JOURNAL OF HEPATOLOGY

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

(2011) M. Sasso et al.   JOURNAL OF VIRAL HEPATITIS

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

(2010) V. W.-S. Wong et al.   GUT

78 VALIDATION OF CONTROLLED ATTENUATION PARAMETER (CAP) AS A NON-INVASIVE MARKER OF STEATOSIS IN 228 PATIENTS WITH CHRONIC LIVER DISEASE FROM VARIOUS CAUSES

(2010) M. Beaugrand et al.   JOURNAL OF HEPATOLOGY

385 CONTROLLED ATTENUATION PARAMETER: A NOVEL FIBROSCAN®-BASED TOOL TO DETECT AND QUANTIFY STEATOSIS. PRELIMINARY STUDY IN PATIENT WITH ALCOHOLOC AND NON ALCOHOLIC FATTY LIVER DISEASE

(2010) M. Beaugrand et al.   JOURNAL OF HEPATOLOGY

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY

Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B

(2009) Grace L-H Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

(2008) G L-H Wong et al.   GUT

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

(2008) H. L.-Y. Chan et al.   JOURNAL OF VIRAL HEPATITIS